Clinical Trial Update: Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update involving insulin degludec in individuals with type 1 diabetes and nocturnal hypoglycemia, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturnal Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• insulin degludec (insulin degludec)

Snippet

Sponsor: Nordsjaellands Hospital | Conditions: Type 1 Diabetes Mellitus, Nocturnal Hypoglycemia | Phase 4 | Status: COMPLETED